LUPKYNIS

View On IC.GC.CA

REGISTERED

on 24 Aug 2022

TM5 Status

LIVE/REGISTRATION/Issued and Active

Your registration has been issued and is active. You can now use the TM5 mark.

Last Applicant/ Owned by

AURINIA PHARMACEUTICALS INC.

1203-4464 Markham StreetVictoria BC V8Z 7X8

Serial Number

2085601 filed on 4^th Jan 2021

Registration Number

TMA1139896 registered on 24^th Aug 2022

Registration expiry Date

4^th Jan 2031

Correspondent Address

BORDEN LADNER GERVAIS LLP

1200 WATERFRONT CENTRE200 BURRARD STREETP.O. BOX 48600VANCOUVER

BRITISH COLUMBIA

V7X1T2

LUPKYNIS

Trademark usage description

pharmaceutical preparations for the treatment of kidney disorders, lupus nephritis and focal segmental glomerulosclerosis.

Vienna Information

24 . 15 . 1

One arrowUne flèche

26 . 3 . 23

Lines or bands forming an angle -- Note: Including chevrons and arrowheads formed by lines or bands.Lignes ou bandes formant un angle -- Note: Y compris les chevrons et les pointes de flèches formées par des lignes ou des bandes.

26 . 11 . 2

Two lines or bandsDeux lignes ou bandes

26 . 11 . 9

Oblique lines or bandsLignes ou bandes obliques

26 . 11 . 10

Straight lines or bandsLignes ou bandes droites

Classification Information

Class [005]
Pharmaceutical preparations for the treatment of kidney disorders, lupus nephritis and focal segmental glomerulosclerosis.

Classification kind code

Mark Details

Serial Number

2085601

Mark Type

Trademark

Legal History

Action Taken	Status
Submitted for opposition 26 on 4^th May 2022	Approved
Submitted for opposition 27 on 4^th May 2022	Approval Notice Sent
Submitted for opposition 22 on 28^th Apr 2022	Search Recorded
Submitted for opposition 256 on 20^th Dec 2021	Notification of Possible Opposition Sent
Submitted for opposition 48 on 16^th Apr 2021	Agent Changed
Submitted for opposition 257 on 18^th Feb 2021	Designation Notification - Madrid Protocol
Submitted for opposition 1 on 17^th Feb 2021	Created
Submitted for opposition 31 on 17^th Feb 2021	Formalized
Submitted for opposition 228 on 4^th Jan 2021	International Registration
Submitted for opposition 30 on 4^th Jan 2021	Filed

Manage cookies

You can choose to enable or disable some or all of these cookies but disabling some of them may affect your browsing experience.

Advertisement cookies are used to provide visitors with customized advertisements based on the pages you visited previously

Analytics

Analytical cookies are used to understand how visitors interact with the website.

Functional

Functional cookies help perform certain functionalities like collecting feedback, and other third-party features.

Performance

Performance cookies are used to understand and analyze the key performance indexes of the website.

LUPKYNIS

Classification Information

Class [005]Pharmaceutical preparations for the treatment of kidney disorders, lupus nephritis and focal segmental glomerulosclerosis.

Classification kind code

Mark Details

Serial Number

Mark Type

Legal History

Class [005]
Pharmaceutical preparations for the treatment of kidney disorders, lupus nephritis and focal segmental glomerulosclerosis.